Keywords: imutec, suspends, virulizin, trials, canadian, biotechnology, firm

Imutec Suspends Virulizin Trials

Article | 31 July 1995

Canadian biotechnology firm Imutec has suspended all clinical trials of its anticancer drug Virulizin in a major restructuring drive. This ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in